Weight loss drug showdown: semaglutide vs. the rest in Real-World workers

NCT ID NCT05579249

First seen Jan 17, 2026 · Last updated Jun 13, 2026 · Updated 26 times

Summary

This study tested how well semaglutide (Wegovy) helps people with obesity lose weight compared to four other approved weight loss medications. About 500 employees from three US companies took part. The goal was to see which drug works best for weight loss and improves quality of life and work ability.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Nutrition Research Centre

    Loma Linda, California, 92354, United States

Conditions

Explore the condition pages connected to this study.